Introduction
Sam68 (Src-associated in mitosis; 68 kDa) is an RNA binding protein first characterized as a mitotic target for overexpressed c-Src in mouse NIH3T3 fibroblasts (Fumagalli et al., 1994; Taylor and Shalloway, 1994) , and as a tyrosine phosphorylated protein associating with the T-cell-specific Src kinase p56 lck in leukemic T-cell lines and mitogen activated T lymphocytes (Vogel and Fujita, 1995) . It is predominantly localized to the nucleus and thought to interact with Src kinases upon nuclear envelope breakdown during mitosis (Fumagalli et al., 1994; Taylor and Shalloway, 1994) . RNA binding ability and association with signaling molecules has categorized Sam68 as a member of the STAR (signal transduction and activation of RNA) family of RNA binding proteins. STAR proteins share a conserved RNA binding KH (hnRNP-K homology) motif contained within a larger conserved GSG (GRP33, Sam68, and GLD-1) domain (Jones and Schedl, 1995; Vernet and Artzt, 1997) . The GSG domain has approximately 200 amino acids (aa) and is conserved among a subfamily of KH-containing proteins, including Artemia salina GRP33 (Cruz-Alvarez and Pellicer, 1987) , Caenorrhabditis elegans germ-line-specific tumor suppressor GLD-1 (Jones and Schedl, 1995) , the mouse quaking gene products (QKI-5, -6, and -7) (Chen and Richard, 1998; Wu et al., 1999) , the fragile X mental retardation gene product FMR-1 (Siomi et al., 1993) , the splicing factor SF1 (Arning et al., 1996) , and mammalian Sam68 and its homologues SLM-1 and SLM-2 (Di Fruscio et al., 1999) . Sam68 demonstrates specificity for homopolymeric poly(U) RNA, and has been shown to bind selectively to RNA sequences containing a UAAA motif (Taylor and Shalloway, 1994; Chen et al., 1997; Lin et al., 1997) . Tyrosine phosphorylation by the Src family kinase fyn and Breast tumor kinase (BRK) was shown to negatively regulate Sam68 binding to poly(U) RNA (Wang et al., 1995; Derry et al., 2000) .
Evidence suggests that Sam68 may play a key role in cell cycle regulation. Not only is Sam68 the only known target for Src during mitosis but it was also reported to be a target for the cyclin B/Cdc2 kinase complex that triggers mitotic progression (Resnick et al., 1997) . Barlat et al. (1997) demonstrated that a splice variant of Sam68 lacking most of the RNA binding KH domain was specifically expressed in quiescent cells (Barlat et al., 1997) . This naturally occurring splice variant is thought to antagonize Sam68 function. Its overexpression in cSrc transformed NIH3T3 cells was shown to induce cell cycle arrest. To examine directly the role played by Sam68 in cell cycle progression, Li et al. (2002) generated a Sam68-deficient chicken DT40 B cell line by gene disruption. The Sam68-deficient cells exhibited a significantly reduced growth rate due to an extended G2-M phase (Li et al., 2002) . Exogenous expression of Sam68 within the cell line could reverse the growth effect. Owing to its ability to bind RNA and its role in cell cycle progression, Sam68 is thought to be involved in regulating gene expression during the cell cycle. Dysfunctional mechanisms regulating Sam68 activity could therefore contribute to neoplastic transformation.
Although the biological role(s) and physiological RNA targets for Sam68 are unknown, it has been shown to substitute functionally for, and synergize with, the HIV-1 Rev protein (Reddy et al., 1999 (Reddy et al., , 2000 (Reddy et al., , 2002 Soros et al., 2001) . This viral protein enhances gene expression on a post-transcriptional level by shuttling unspliced viral messages from the nucleus to the cytoplasm. However, Coyle et al. (2003) reported that Sam68 functions to enhance the cytoplasmic utilization of RNA harboring a retroviral transport sequence, and suggest that Sam68 may influence gene expression by regulating the cytoplasmic fate of RNA rather than its nuclear export (Coyle et al., 2003) . Interestingly, tyrosine phosphorylation by BRK was shown to negatively regulate Sam68 function in post-transcriptional gene expression by inhibiting its RNA binding ability (Derry et al., 2000; Coyle et al., 2003) .
Acetylation is a reversible post-translational modification of lysine residues that can affect chromatin structure and influence transcription by modifying protein affinity for DNA (Kouzarides, 2000) . Although several acetyltransferases are known to acetylate histones, the acetyltransferases CBP and p300 (two proteins that are highly homologous both structurally and functionally) and PCAF also have various nonhistone substrates (Sterner and Berger, 2000) . For example, CBP can acetylate the transcription factors p53 (Gu and Roeder, 1997) , E2F1 (Martinez-Balbas et al., 2000) , GATA-1 (Boyes et al., 1998) , and EKLF . However, only two cellular nonhistone, non-DNA binding proteins, the cytoplasmic protein tubulin and the shuttling protein importin a, both of which are functionally unrelated to transcription, have been demonstrated to be acetylated (L'Hernault and Rosenbaum, 1985; Bannister et al., 2000) . The consequence of acetylation of these proteins is still unclear.
Since acetylation is a common post-translational modification known to influence protein -nucleic acid interactions, we investigated if the RNA binding protein Sam68 could be acetylated. We demonstrate endogenous Sam68 to be acetylated. A survey of several human mammary epithelial cell lines revealed Sam68 acetylation to be highest in tumorigenic cell lines. There was a positive correlation between Sam68 acetylation and its ability to bind RNA for these cell lines. We also report CBP is one acetyltransferase that can acetylate Sam68 and stimulate its ability to bind homopolymeric poly(U) RNA. These results suggest that acetylation of Sam68 may increase its activity by enhancing its ability to bind RNA. This may lead to an increase in the expression of genes regulated by Sam68 and may contribute to tumor cell proliferation.
Results

Endogenous Sam68 is acetylated
Several reports have identified Sam68 as a target for tyrosine kinases. Phosphorylation on tyrosine residues, which are mostly located within the C-terminal region of Sam68, could negatively regulate its ability to bind RNA. We considered the possibility that Sam68 may also be targeted by acetyltransferases. The majority of potential acetylation sites within Sam68 are actually clustered within the RNA binding KH domain. In fact, 21 of the 24 lysine residues within Sam68 are located in the highly conserved GSG domain containing the RNA binding region (Figure 1a) . Interestingly, two lysines not within the GSG domain flank the putative nuclear localization signal (NLS) (Ishidate et al., 1997) . To examine if Sam68 was acetylated in vivo, 293T cells were labeled with [
14 C] Na acetate for 90 min. Lysates were then prepared and Sam68 was immunoprecipitated. Immunoprecipitates were then analysed by SDS-PAGE and autoradiography. Sam68 could be detected in the autoradiogram, suggesting that it was acetylated in 293T cells ( Figure 1b) . As further proof of Sam68 acetylation in 293T cells, we analysed immunoprecipitated Sam68 by Western blotting with an anti-acetyl lysine (AK) antibody. This antibody could detect Sam68 immunoprecipitated from 293T cells but could not detect recombinant GST-Sam68 up to 300 ng ( Figure 1c ).
Sam68 acetylation is elevated in several tumorigenic human mammary cancer cell lines
To examine if Sam68 was acetylated in other cell types, we screened several human mammary epithelial tumor and control cell lines. Immunoprecipitation (IP) of Sam68 and Western blotting with the anti-AK antibody revealed differences in the level of Sam68 acetylation within these cell lines. Interestingly, the anti-AK antibody could detect Sam68 acetylation in four of the five tumor cell lines, but could not detect significant acetylation on Sam68 in the normal breast epithelial cell lines (Figure 2 ). It is possible that Sam68 acetylation in the normal control cell lines and the SK-BR3 cell line is below the detectable sensitivity of the anti-AK antibodies. Tyrosine phosphorylation of Sam68 is a well-characterized mechanism regulating Sam68 function. We therefore also investigated the tyrosine phosphorylation status of Sam68 for these cell lines by Western blotting with an antiphosphotyrosine antibody. Sam68 was found to be phosphorylated in three tumor cell lines (Hs578T, MDA-435, and MDA-468) but not in any of the control cell lines (Figure 2 ).
Level of Sam68 acetylation positively correlates with RNA binding
Acetylation has been reported as a mechanism regulating the DNA binding properties of several proteins (Sterner and Berger, 2000) . We therefore examined if there was any correlation between Sam68 acetylation and its ability to bind RNA for the mammary epithelial cell lines. Interestingly, the four cell lines in which Sam68 could bind poly(U) RNA were the same cell lines in which Sam68 was acetylated ( Figure 3 ). Previous reports have demonstrated that tyrosine phosphorylation of Sam68 by Src family kinases and BRK can negatively regulate its affinity for poly(U) RNA. However, Sam68 was not found to be tyrosine phosphorylated in the cell lines that showed very poor binding of Sam68 to poly(U) RNA (Figure 2 ). The cell line exhibiting Sam68 with the highest affinity for poly(U) RNA was BT-483 ( Figure 3 ). Sam68 from this cell line was found to be acetylated but not tyrosine phosphorylated. Interestingly, three of the cell lines (Hs578T, MDA-435, and MDA-468) that showed Sam68 binding to RNA actually had a high degree of tyrosine phosphorylation on Sam68. These same cell lines also displayed the highest level of Sam68 acetylation ( Figure 2 ). Thus, the RNA binding activity of Sam68 from each of the cell lines positively correlated with its acetylation.
CBP can acetylate Sam68 in vitro
The acetyltransferase CBP has been shown to acetylate a diverse group of nonhistone proteins (Sterner and Berger, 2000) , and has been reported to associate with Sam68 (Hong et al., 2002) . We therefore examined if Sam68 could be a substrate for CBP. An in vitro acetylation reaction was performed using the GST-CBP HAT domain and either GST alone or GST-Sam68, followed by P81 filter binding assay to detect protein acetylation ( Figure 4a ). Core histones (200 ng) were included as a positive control. GST-Sam68, but not GST alone, could be acetylated by the GST-CBP HAT domain in vitro (Figure 4a ).
To examine if the anti-AK antibody could detect Sam68 acetylation by CBP, in vitro acetylation reactions were performed and then resolved by SDS-PAGE and analysed by Western blotting. The antibody could detect GST-CBP HAT domain autoacetylation (data not shown) and GST-Sam68 acetylation (Figure 4b -left  panel) . However, the antibody could not detect any acetylation of GST alone, even when higher concentrations of GST were used (Figure 4b -right panel) . Thus the acetylation detected for GST-Sam68 was a result of Sam68 and not GST acetylation.
To investigate which region(s) of Sam68 could be acetylated by CBP, the amino terminal (aa 1-160) region, the central (aa 160-330) region harboring the KH domain, and the carboxy terminal (aa 330-443) region of Sam68 were fused to GST (Figure 5a ). These constructs were used in an in vitro acetylation reaction with GST-CBP HAT domain. Western blot analysis using the anti-AK antibody revealed a greater degree of acetylation on the amino terminal region of Sam68 (Figure 5b ). The amino terminus (aa 1-160) of Sam68 contains 10 lysines in the region adjacent to the KH RNA binding domain (Figure 1a ). Figure 3 The degree of Sam68 acetylation correlates with its RNA binding activity. Whole-cell lysates from the cell lines in Figure 2 were used in poly(U) RNA agarose or agarose alone pull-down experiments. The amount of Sam68 in the whole-cell lysates prior to pull-downs is demonstrated along with the amount of Sam68 pulled down. One representative experiment of at least four independent experiment is shown Inhibition of histone deacetylase (HDAC) activity or overexpression of CBP can stimulate Sam68 acetylation in vivo
To examine if the anti-AK antibody can specifically detect an increase in Sam68 acetylation in vivo, we transiently transfected 293T cells with either empty vector or Sam68. At 48 h post-transfection, the cells were incubated with the HDAC inhibitors sodium butyrate (NaB) and trichostatin A (TSA) for 1.5 h before whole-cell lysates were prepared. As shown in Figure 6a , the deacetylase inhibitors induced the acetylation of several proteins in 293T cells. Although we observed Sam68 acetylation in the untreated cells, its acetylation was significantly increased in the presence of the deacetylase inhibitors (Figure 6a ).
To address whether CBP could influence Sam68 acetylation in vivo, we transiently transfected 293T cells with either vector alone, CBP-HA alone, Sam68 alone, or CBP-HA with Sam68. The acetylation of numerous proteins was observed to increase when CBP was overexpressed ( Figure 6b ). Sam68 acetylation was also increased in the presence of CBP (Figure 6b ). Thus expression of CBP can stimulate Sam68 acetylation in vivo. Interestingly, we consistently noticed that overexpression of Sam68 could inhibit the expression of the cotransfected CBP-HA vector (see anti-HA blot Figure 6b) . Hong et al. (2002) reported Sam68 functions as a transcriptional repressor, and has potent transcriptional repression activity similar to the adenoviral E1A oncoprotein. We observed this same phenomenon in our transfection experiments with the HEK293T cells. The inhibition of CBP coexpression by Sam68 may have therefore limited the extent of acetylation that we observed on Sam68.
Acetylation can increase Sam68 RNA binding activity
Since we observed a positive correlation between Sam68 acetylation and RNA binding ability for the tumor cell lines, we investigated if acetylation of Sam68 by CBP could impact its ability to bind RNA. In vitro acetylation of GST-Sam68 with GST-CBP HAT domain followed by poly(U) RNA agarose pull-down demonstrated an increased amount of GST-Sam68 associating with poly(U) RNA agarose, indicating that acetylation could increase Sam68 binding to RNA (Figure 7a ). The degree of acetylation was found to correlate with the amount of GST-Sam68 pulled down with poly(U) RNA agarose. In the absence of the GST-CBP HAT domain, we did not detect significant binding of GST-Sam68 to poly(U) RNA agarose (data not shown).
To test if CBP could regulate Sam68 RNA interaction in vivo, we coexpressed CBP and Sam68 in NIH3T3 cells. Poly(U) RNA agarose pull-downs demonstrated that CBP but not vector alone could enhance Sam68 binding to poly(U) RNA (Figure 7b ). CBP did not stimulate Sam68 association with the agarose alone control.
CBP may not be the only acetyltransferase that can regulate Sam68 acetylation in vivo
To examine if Sam68 acetylation in the tumor cell lines may be due to CBP, we screened the cell lines for CBP histone acetyltransferase (HAT) enzyme activity by IP-HAT assay. The three cell lines Hs578T, MDA-435, and MDA-468 that displayed a high level of Sam68 acetylation and RNA binding also had the highest CBP activity (Figure 8) . Interestingly, Sam68 from these cell lines was also found to be tyrosine phosphorylated (Figure 2 ). CBP HAT activity did not perfectly correlate with Sam68 acetylation. Sam68 from the tumor cell line BT-483 was found to be acetylated and have a very high affinity for RNA; Figure 6 Sam68 acetylation in vivo can be enhanced by inhibiting HDACs or by overexpression of CBP. (a) 293T cells were transiently transfected with either empty vector or Sam68 (2 mg). At 48 h post-transfection, the HDAC inhibitors TSA and NaB were added (5 mM and 15 mM, respectively) and incubated with the cells for 1.5 h prior to cell lysis. Whole-cell lysates were probed with anti-AK antibody and the membrane was subsequently reprobed with anti-Sam68. (b) 293T cells were transiently transfected with 2 mg of empty vector, or CBP-HA alone, or Sam68 alone, or CBP-HA (2 mg) and Sam68 (2 mg). The amount of DNA for each transfection was equalized to 4 mg with the pCI empty vector. At 48 h post-transfection, cells were lysed and whole-cell lysates were Western blotted with the anti-AK antibody. The membrane was then reprobed with anti-Sam68 and anti-HA (a) In total, 1 mg of GST-Sam68 was acetylated in vitro with 250 ng of GST-CBP HAT domain. Half the reaction was resolved by SDS-PAGE and Western blotted with anti-AK. The filter was then stripped and reprobed with anti-Sam68 to show GST-Sam68 input for poly(U) RNA agarose pull downs. The other half of the acetylation reaction was used for poly(U) RNA pull down. The amount of Sam68 pulled down by poly(U) RNA agarose is shown by anti-Sam68 Western blot. Blots from one of four independent experiments are shown. (b) Poly(U) RNA agarose, or agarose alone, pull-down experiments using whole-cell lysates from NIH3T3 cells transiently transfected with Sam68 (1 mg) and either CBP-HA (2 mg) or empty vector (2 mg). The amount of Sam68 in the lysates prior to pull-downs and the amount of Sam68 pulled down is shown by anti-Sam68 Western blot. Representative blots from one of three independent experiments are shown however, CBP activity was lowest within this cell line (Figure 8 ). The fact that Sam68 acetylation could be detected in the BT-483 cell line, which showed very low CBP enzyme activity, suggests that one or more acetyltransferases other than CBP (or possibly some other contributing factor) also might be involved in the acetylation of Sam68 in vivo.
Discussion
It has previously been demonstrated that Sam68 has a preference for binding homopolymeric poly(U) RNA (Taylor and Shalloway, 1994; Chen et al., 1997; Lin et al., 1997) . Tyrosine phosphorylation by the Src kinase fyn and BRK has been shown to regulate this RNA binding negatively (Wang et al., 1995; Derry et al., 2000) . As of yet there have been no reports identifying a protein, such as a phosphatase, that can positively regulate Sam68 binding to RNA. Here we report that the RNA binding protein Sam68 is acetylated in vivo, and that acetylation may act as a novel mechanism for positively regulating its RNA binding activity.
We demonstrated that endogenous Sam68 is acetylated in 293T cells and that the anti-AK antibody could detect Sam68 acetylation (Figure 1 ). Various nonhistone proteins are known to be substrates for acetyltransferases. However, most of these are DNA binding proteins and are functionally involved in transcription (Sterner and Berger, 2000) . Sam68 is the first cellular RNA binding protein reported to be acetylated. RNA binding proteins represent a new class of substrates for acetyltransferases. The HIV-1 viral RNA binding trans-activator protein, Tat, was shown to be a substrate for the acetyltransferases p300 and PCAF (Kiernan et al., 1999) . Acetylation within the RNA binding domain of Tat by p300 inhibits Tat binding to the trans-activation responsive region (TAR) RNA, which promotes the transcription of viral messages (Kiernan et al., 1999) . In contrast, acetylation of Sam68 by CBP in vitro appears to occur within the amino terminal region flanking the RNA binding domain ( Figure 5) .
A screen of several human mammary epithelial cell lines revealed significant variations in Sam68 acetylation, with the highest level detected in tumorigenic cell lines (Figure 2) . It is unknown if Sam68 acetylation contributes in any way to the tumor cell phenotype. Increased acetylation of other proteins such as Rb and Myc is thought to contribute to cell proliferation by stimulating gene expression (Chan et al., 2001; Vervoorts et al., 2003) . Although the true biological relevance of Sam68 acetylation in the tumor cell lines remains to be determined, we observed a positive correlation between acetylation and the ability to bind poly(U) RNA (Figure 3 ). It is possible that enhanced acetylation of Sam68 in the tumor cell lines may stimulate its function in RNA processing and increase gene expression on a post-transcriptional level. Increased expression/activity of RNA binding proteins in tumors has previously been reported (Perrotti and Calabretta, 2002) . In fact, a KH domain-containing protein has been implicated in tumor cell proliferation because its expression was found to be exclusive to tumors and embryonic tissue (Mueller et al., 2003) . In other studies, Mandal et al. (2001) reported that the KH domain-containing RNA binding protein hnRNP K was upregulated in breast cancer cells. Its overexpression was shown to increase c-Myc protein and enhanced breast cancer cell proliferation and growth in an anchorage-independent manner (Mandal et al., 2001) .
The results presented in this report suggest that acetylation might influence Sam68 affinity for RNA substrates. In fact, it appears that there may be a complex post-translational modification code regulating Sam68 binding to RNA substrates. For some tumor cell lines, we observed Sam68 to be both tyrosine phosphorylated and acetylated, and still able to bind RNA (Figures 2 and 3) . However, we cannot rule out the possibility that acetylated Sam68 and tyrosine phosphorylated Sam68 are derived from two different intracellular pools. It will be important to establish how tyrosine phosphorylation and acetylation of Sam68 are related, and how both impact Sam68 function. Interestingly, the three cell lines in which Sam68 is found to be tyrosine phosphorylated (Hs578T, MDA-435, and MDA-468) also exhibit Sam68 with the highest level of acetylation and CBP enzyme activity (Figures 2 and 8) . It is possible that one posttranslational modification on Sam68 might influence the other. Hong et al. (2002) identified Sam68 as a CBPinteracting molecule by a yeast two-hybrid screen (Hong et al., 2002) . We have also observed Sam68 and CBP interaction by coimmunoprecipitation, and could detect some colocalization of Sam68 with CBP by immuno- fluorescence microscopy (data not shown). However, Hong et al. did not report significant acetylation of Sam68 by CBP. Here we show that the CBP HAT domain can acetylate Sam68 directly in vitro (Figure 2) . Also, overexpression of CBP can stimulate Sam68 acetylation in vivo (Figure 6 ). Whether this is a direct or indirect result of CBP HAT activity is still unclear. CBP acetyltransferase activity has been shown to peak at the G1/S transition (Ait-Si-Ali et al., 2000) . Interestingly, we have obtained preliminary evidence, which suggests that Sam68 acetylation increases at the G1/S phase of the cell cycle (data not shown). It is possible that CBP regulation of Sam68 acetylation could be cell cycle specific.
Although CBP can acetylate Sam68 in vitro, it appears that other acetyltransferases contribute to Sam68 acetylation in vivo. For example, within the BT-483 cell line, Sam68 is shown to be acetylated but CBP HAT activity is found to be very low (Figure 8 ). This would suggest that other acetyltransferases might utilize Sam68 as a substrate. Thus, for the cell lines Hs578T, MDA-435, and MDA-468 in which Sam68 is also acetylated, although CBP HAT activity was found to be very high, other acetyltransferases might contribute to the observed acetylation on Sam68.
This report suggests that acetyltransferases might be directly involved in the regulation of RNA metabolism. In fact, RNA processing events such as splicing may be regulated by acetylation. Interestingly, Sam68 has been shown to associate directly, and colocalize, with splicing factors (Hartmann et al., 1999) . Also, Sam68 can assemble on introns along with other splicing factors, suggestive of a possible role in splicing (Grossman et al., 1998) . The STAR protein SLM-2 (Sam68-like mammalian protein-2), a homologue of Sam68 with a highly conserved RNA binding KH domain and GSG domain, has been shown to influence splice site selection (Stoss et al., 2001) . In fact, Sam68 itself has recently been reported to function as a regulator of alternative splicing (Matter et al., 2002) . Acetylation could therefore link transcriptional control with splice site selection and expression of alternate isoforms. Thus, acetylation may be an important mechanism not only for regulating the output of the genome but also for regulating the diversity of this output.
Materials and methods
Cell lines, transfections, and IPs
Human renal 293T, NIH3T3, and human mammary epithelial tumor cell lines SK-BR3, BT-483, Hs578T, MDA-435, and MDA-468 (ATCC) were maintained in Dulbecco's modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum and 100 mg/ml penicillin/streptomycin antibiotics. Human mammary epithelial control cell lines MCF-10A, MCF-10-2A, and MCF-12A (ATCC) were maintained in MEGM (Mammary Epithelial Growth Medium, Serum-free) from Clonetics supplemented with 100 ng/ml cholera toxin (Calbiochem). Transfection of 293T cells was performed with Lipofectamine 2000 (Invitrogen) and transfection of NIH3T3 cells was performed using FuGENE 6 (Roche) according to the manufacturer's instructions. Cells were lysed 48 h post-transfection with Triton lysis buffer (1% Triton X-100, 25 mM Tris-HCl pH 7.4, 150 mM NaCl) with inhibitors (1 mM Na 3 VO 4 , 1 mM PMSF, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 2 mg/ml pepstatin, 25 mM NaF, and 10 mM pNPP), and with or without the HDAC inhibitors trichostatin A (TSA from Sigma) at 5 mM, or TSA with NaB (from Sigma) at 10 mM. IP's from 1 mg lysate in 1 ml volume were performed with 1 mg antibody for 2 h, after which 20 ml of 50% solution of protein A/G Plus (Santa Cruz Biotechnology, Inc.) was added and the mixture incubated on a rotator overnight at 41C. Immunoprecipitates were pelleted, washed three times with lysis buffer, resuspended in Laemmli sample buffer, and resolved by SDS-PAGE. IPs and Western blots were performed using the following antibodies: anti-Sam68 (C-20 polyclonal from Santa Cruz Biotechnology, Inc.), anti-acetyl lysine (AK) (polyclonal from Cell Signaling Technology), 4G10 antiphosphotyrosine (kindly provided by Dr S Robbins, University of Calgary), anti-CBP (A-22 polyclonal from Santa Cruz Biotechnology, Inc.), and anti-HA (monoclonal from Cell Signaling Technology). Western blots were developed using enhanced chemiluminescence reagents (ECL from Amersham).
Plasmids construction
A Sam68 cDNA clone isolated from a human T-lymphocyte cDNA library was used to generate a GST-Sam68 full-length fusion. The coding region of Sam68 was polymerase chain reaction (PCR) amplified and cloned into pGEX-4T-3. The PCR-amplified coding region of the human Sam68 cDNA was also cloned into the mammalian expression vector pCI (Promega). To generate the GST-1-160 amino terminal Sam68 fusion construct the region of Sam68 from amino acids 1 to 160 was PCR amplified using the sense primer 5 0 -TGAATTCTATGCAGCGCCGGACGA-3 0 (the EcoRI site is underlined) and the antisense primer 5 0 -ACGCGTCGAC-CAGCACTCGCTCTTTC-3 0 (the SalI site is underlined). The corresponding PCR fragment was digested with EcoRI/SalI and cloned into pGEX-4T-3. To generate the GST-160-330 central Sam68 fusion construct, the central region of Sam68 was PCR amplified using the sense primer 5 0 -AT-GAATTCTCTGATACCTGTCAAGC-3 0 (the EcoRI site is underlined) and the antisense primer 5 0 -ACGCGTCGACT-TACACAGTGGCACCTCTGG-3 0 (the SalI site is underlined). The corresponding PCR fragment was digested with EcoRI/SalI and cloned into pGEX-4T-3. To generate the GST-330-443 carboxy terminal Sam68 fusion construct, the carboxy terminal region of Sam68 was PCR amplified using the sense primer 5 0 -ATGAATTCTACTCGAGG-CGTGCC-3 0 (the EcoRI site is underlined) and the antisense primer 5 0 -TTCCCCCGGGTTTAATAACGTCCATATGGG-TGC-3 0 (the SmaI site is underlined). The corresponding PCR fragment was digested with EcoRI/SmaI and cloned into pGEX-4T-3.
The GST-CBP HAT domain (aa 1098-1758) construct was previously described (Bannister and Kouzarides, 1996) and was kindly provided by Dr T Kouzarides (Wellcome CRC Institute, Cambridge). The mouse CBP-HA cDNA was subcloned from the vector pRc/RSV-mCBP-HA (Takemaru and Moon, 2000) , which was kindly provided by Dr R Goodman (Vollum Institute, Portland Oregon), into the pCI expression vector. All plasmid constructs were sequenced to verify identities.
In vivo labeling
293T cells were labeled in vivo with 20 mCi [ 14 C] Na acetate for 90 min. Whole-cell lysates were isolated and immunoprecipitated with either anti-Sam68 or isotype control antibody. IPs were analysed by SDS-PAGE and autoradiography.
In vitro acetylation, P81 filter binding assay, and IP-HAT assay These were performed as previously described by Bannister and Kouzarides (1996) .
Poly(U) RNA pull-downs
For in vitro studies, 1 mg of full-length GST-Sam68 was acetylated with 500 ng GST-CBP HAT domain in a standard acetylation reaction and subsequently used for poly(U) RNA agarose pull-downs. For in vivo studies, cells were transfected as described and lysed 48 h post-transfection in Triton lysis buffer with TSA. In total, 20 ml of a 50% solution of poly(U) RNA agarose beads (Amersham Pharmacia Biotech), or agarose beads alone (Sigma), were added to 25 mg-100 mg of whole-cell lysates in 1 ml of lysis buffer containing 2 mg/ml heparin (Sigma) and 2% Triton X-100. This was rotated at 41C for 30 min. The beads were then pelleted, washed three times with lysis buffer containing Heparin and 2% Triton X-100, then washed once with phosphate-buffered saline and resuspended in Laemmli sample buffer and probed for associated Sam68 by Western blotting.
